Fifth Third Bancorp »

Cognition Therapeutics shares owned by Fifth Third Bancorp

Quarter-by-quarter ownership of Cognition Therapeutics (CGTX) shares owned by Fifth Third Bancorp from 13F filings

Historical chart of Fifth Third Bancorp investment in Cognition Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cognition Therapeutics held by Fifth Third Bancorp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cognition Therapeutics by Fifth Third Bancorp

Quarter filed Position value Share count Share price at filing
2025-12-31 $6.8k 5.0k 1.35

More positions owned by Fifth Third Bancorp

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core S&p500 Etf (IVV)
Broadcom (AVGO)
Amazon (AMZN)
Ishares Tr S&p 100 Etf (OEF)
JPMorgan Chase & Co. (JPM)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Mastercard Incorporated Cl A (MA)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Abbvie (ABBV)

View all positions for Fifth Third Bancorp

Top funds holding Cognition Therapeutics

BIOS Capital Management
Vanguard Group
Davenport & Co
BlackRock
Chescapmanager
Renaissance Technologies
Geode Capital Management
Jane Street
Millennium Management
Hilton Capital Management
Dauntless Investment Group
State Street Corporation
Voss Capital
Sigma Planning
American Financial Group

View all funds holding Cognition Therapeutics